NCT04487990View on ClinicalTrials.gov

CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

April 3, 2021

Conditions
Acute Kidney InjuryCovid19
Interventions
DRUG

unfractionated Heparin

Addition of unfractioned heparin to CVVHD system already running under citrate regional anticoagulation.

Trial Locations (1)

05403-010

University of São Paulo General Hospital, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT04487990 - CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 | Biotech Hunter | Biotech Hunter